ARCHIVES

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

Funding Opportunities

October 25, 2002

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos

May 9, 1997

ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval

September 13, 2013